pharmaceutical investing Auris Medical Closes Two US Patent Acquisitions Related to the Use of Betahistine for the Treatment of Depression and ADHD
pharmaceutical investing Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss
Apollo Files NI 43-101 Technical Report for the Calico Silver Project Updated Mineral Resource Estimate
